{"result": {"id": "5d6adcc1-8c44-4fd1-aa79-6ca3e10d9bfc", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Cardiovascular and Hypertension Research Community\",\n    \"summary\": \"This community is centered around cardiovascular and hypertension research, with key entities including JAMA Neurology, European Heart Journal (Eur Heart J), and prominent researchers like Kario K and Mancia G. The community's structure is defined by collaborative research studies, clinical trials, and the development of hypertension management guidelines. Significant relationships include collaborations between researchers and publications in leading journals, highlighting the community's focus on advancing cardiovascular health and hypertension treatment.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's significant contributions to cardiovascular health research and hypertension management, influencing clinical practices globally.\",\n    \"findings\": [\n        {\n            \"summary\": \"Leading journals as central entities\",\n            \"explanation\": \"JAMA Neurology and European Heart Journal (Eur Heart J) serve as central entities in this community, publishing pivotal studies on blood pressure, cognitive outcomes, and cardiovascular health. Their publications have significantly contributed to the understanding and management of hypertension and related conditions. [Data: Entities (3328, 2148), Relationships (3444)]\"\n        },\n        {\n            \"summary\": \"Prominent researchers and their contributions\",\n            \"explanation\": \"Researchers like Kario K and Mancia G have made substantial contributions to hypertension research, including studies on home blood pressure monitoring, nocturnal blood pressure, and the development of hypertension guidelines. Their work has been instrumental in shaping current hypertension management practices. [Data: Entities (2305, 2446), Relationships (2552, 2641)]\"\n        },\n        {\n            \"summary\": \"Clinical trials and their impact\",\n            \"explanation\": \"Clinical trials such as the HERB-DH1 PIVOTAL TRIAL and the JET study have explored innovative treatments for hypertension, including digital therapeutics and eplerenone. These trials contribute valuable evidence for the efficacy of new treatment modalities. [Data: Entities (3855, 2899), Relationships (3824, 3005)]\"\n        },\n        {\n            \"summary\": \"Collaborative guidelines development\",\n            \"explanation\": \"The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) have collaborated on the development of hypertension management guidelines, reflecting a unified approach to cardiovascular health. These guidelines are pivotal in standardizing treatment protocols across Europe. [Data: Entities (2438, 2439), Relationships (2631)]\"\n        },\n        {\n            \"summary\": \"Focus on elderly and special populations\",\n            \"explanation\": \"Research within the community extensively covers hypertension management in elderly populations and specific ethnic groups, such as Eastern Asians. Studies like the Hypertension in the Very Elderly Trial (HYVET) and the ARTEMIS study address unique challenges in these populations. [Data: Entities (3152, 3163), Relationships (3310, 3319)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560554, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 608, "prompt_tokens": 6843, "total_tokens": 7451, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1536}, "prompt_cache_hit_tokens": 1536, "prompt_cache_miss_tokens": 5307}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3328,JAMA NEUROL,\"JAMA Neurology published associations between midlife vascular risk factors and 25-year incident dementia in the ARIC cohort\"\"\nJAMA Neurology published a study on the effect of standard vs intensive blood pressure control on the risk of recurrent stroke\"\"\",5\n2148,EUR HEART J,\"The *European Heart Journal (Eur Heart J)* is a leading European journal dedicated to publishing high-quality research in cardiovascular medicine. It covers a broad range of topics, including salt intake and cardiovascular disease, digital therapeutics for hypertension, and novel treatments such as sacubitril-valsartan for apparent resistant hypertension in patients with heart failure and preserved ejection fraction (as demonstrated in a 2021 study). The journal has also explored the association between systolic blood pressure and dementia, as evidenced by findings from the Whitehall II cohort study. Recognized as a prominent publication in cardiology, *Eur Heart J* serves as a key resource for advancing research and clinical practice in cardiovascular health.\",12\n3855,HERB-DH1 PIVOTAL TRIAL,A clinical trial on digital therapeutics for hypertension published in Eur Heart J,2\n2161,O'DONNELLM,A researcher involved in a study on salt and cardiovascular disease>,1\n2162,MENTEA,A researcher involved in a study on salt and cardiovascular disease>,1\n2163,ALDERMAN MH,A researcher involved in a study on salt and cardiovascular disease>,1\n2173,KIM MS,A researcher involved in a study on the association between adiposity and cardiovascular outcomes>,1\n2174,KIM WJ,A researcher involved in a study on the association between adiposity and cardiovascular outcomes>,1\n2175,KHERAAV,A researcher involved in a study on the association between adiposity and cardiovascular outcomes>,1\n3337,WHITEHALL II,\"The Whitehall II cohort study investigated the association between systolic blood pressure and dementia\"\"\",1\n2305,KARIO K,\"**Kario K** is a prominent researcher specializing in hypertension management, with a particular focus on Eastern Asian populations. He has been involved in numerous large-scale studies and clinical trials, including the **HERB-DH1 pivotal trial** on digital therapeutics for hypertension, the **SPYRAL HTN Global Clinical Trial Program**, and the **ARTEMIS** study. His work extensively explores **home blood pressure monitoring**, **nocturnal blood pressure**, and **morning hypertension**, contributing significantly to the understanding of cardiovascular outcomes.  \n\nKario K plays a key role in the **HOPE Asia Network**, where he has contributed to consensus statements on **home blood pressure monitoring** and **morning hypertension management**. His research spans observational studies, such as those examining home blood pressure and cardiovascular outcomes, as well as interventional trials aimed at improving hypertension treatment strategies. Through his involvement in these initiatives, Kario K has established himself as a leading figure in hypertension research, particularly in addressing regional and global challenges in blood pressure management.\",9\n2342,HONEST STUDY,,3\n2703,WANG JIANGUANG,\"Wang Jianguang is a researcher involved in studies on hypertension management in Eastern Asians.\"\"\",3\n2375,WANG TD,\"WANG TD is a researcher specializing in hypertension drug studies and has contributed to the field as a co-author of the HOPE Asia Network consensus statement. Their work reflects a focus on cardiovascular health, particularly in the Asian context, through both research and collaborative guideline development.\",2\n2376,TOMITANI N,\"Co-author of HOPE Asia Network consensus statement\"\"\",1\n2446,MANCIA G,\"**MANCIA G** is a prominent researcher specializing in hypertension and related cardiovascular conditions. He has been involved in multiple studies, including investigations into white-coat hypertension and the effects of long-term antihypertensive treatment on this condition. Additionally, his work extends to research on blood pressure targets in patients with type 2 diabetes. Mancia G is recognized as a key figure in the development of hypertension guidelines, particularly those issued by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). His contributions have significantly advanced the understanding and management of hypertension in clinical practice.\",7\n2456,NARKIEWICZ K,\"NARKIEWICZ K is a researcher specializing in hypertension studies, with a focus on single-pill combinations and hypertension control. Notably, NARKIEWICZ K has contributed to the development of the ESH/ESC hypertension guidelines, demonstrating expertise in the field of cardiovascular health and treatment strategies. Their work reflects a commitment to advancing research and clinical practices in hypertension management.\",3\n3140,ELSA STUDY,A study examining the reproducibility of MUCH and WUCH in hypertension research>,3\n3167,ESH,\"European Society of Hypertension\"\"\",2\n2455,FAGARD R,\"Contributor to ESH/ESC hypertension guidelines\"\"\",1\n2860,YANO Y,\"Yano Y is one of the authors of the JET study on eplerenone in elderly hypertensive patients\"\"\",3\n2861,HOSHIDE S,\"HOSHIDE S is a researcher known for their contributions to hypertension studies, particularly in elderly patients. They are one of the authors of the JET study, which investigated the use of eplerenone in elderly hypertensive patients. Additionally, HOSHIDE S has been involved in other significant hypertension research projects, including the ARTEMIS and J-MORE studies. Their work demonstrates a focus on advancing understanding and treatment options for hypertension in aging populations.\",5\n2862,TAMAKI N,\"Tamaki N is one of the authors of the JET study on eplerenone in elderly hypertensive patients\"\"\",3\n3119,BOMBELLI M,\"A researcher involved in multiple hypertension-related studies, including white-coat hypertension>\",1\n3170,J-MORE,,3\n2438,EUROPEAN SOCIETY OF HYPERTENSION (ESH),\"European organization involved in hypertension guidelines\"\"\",3\n2439,EUROPEAN SOCIETY OF CARDIOLOGY (ESC),\"The **European Society of Cardiology (ESC)** is a European organization dedicated to cardiovascular medicine. It plays a key role in developing and disseminating clinical guidelines for cardiovascular care, including the co-publication of the **2019 guidelines for the management of dyslipidaemias**. The ESC serves as a leading authority in shaping cardiovascular practices and standards across Europe.\",4\n2899,JET STUDY,\"The JET study investigated the efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients\"\"\",3\n3152,HYPERTENSION IN THE VERY ELDERLY TRIAL,\"The **Hypertension in the Very Elderly Trial (HYVET)** was a double-blind, placebo-controlled study investigating the effects of antihypertensive treatment in individuals aged 80 and over with hypertension. The trial aimed to assess whether treating high blood pressure in this elderly population provided clinical benefits. Additionally, it explored the question of whether white-coat hypertension—a condition where blood pressure readings are higher in clinical settings but normal elsewhere—required active treatment in patients over the age of 80. The study provided valuable insights into the management of hypertension in very elderly patients, addressing both sustained hypertension and white-coat hypertension scenarios.\",3\n2678,PETERS R,\"PETERS R is a researcher specializing in hypertension and its implications for elderly patients. Their work includes studying white-coat hypertension in the very elderly, as well as investigating the relationship between blood pressure and dementia. PETERS R's research focuses on understanding and improving treatment approaches for hypertension in older populations, contributing to broader knowledge in geriatric medicine and cardiovascular health.\",3\n3163,ARTEMIS STUDY,\"A study comparing ethnic differences in morning blood pressure surge between Japanese and European hypertensive subjects\"\"\",3\n3340,KITAGAWA K,\"Kitagawa K researched standard vs intensive blood pressure control on risk of recurrent stroke\"\"\",1\n3336,ARIC,\"The ARIC cohort study examined associations between midlife vascular risk factors and 25-year incident dementia\"\"\",1\n4571,MACH F,\"Co-author of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias\"\"\",2\n4446,NIACIN,\"Niacin is a drug that has been studied for its effects on high-density lipoprotein (HDL) composition and function. It is used to manage lipid levels and is available in various formulations, including extended-release tablets. Additionally, acipimox, a related compound, is also utilized for lipid management alongside niacin. Together, these treatments play a role in regulating cholesterol and improving cardiovascular health.\",2\n4410,OMEGA-3 FATTY ACIDS,,4\n3133,TADIC M,\"**TADIC M** is a researcher with expertise in cardiovascular health, particularly focusing on the effects of omega-3 fatty acids on coronary artery disease, as well as investigations into nocturnal blood pressure patterns and white-coat hypertension. Their work spans multiple aspects of cardiovascular research, including dietary influences on heart disease and the dynamics of blood pressure variability in clinical and ambulatory settings. This demonstrates a broad research interest in both preventive and diagnostic dimensions of cardiovascular health.\",2\n4680,STRENGTH RANDOMIZED CLINICAL TRIAL,\"A clinical trial comparing high-dose omega-3 fatty acids vs corn oil on cardiovascular events\"\"\",2\n2677,BECKETT NS,A researcher involved in hypertension treatment for elderly patients,2\n2693,EGAN BM,\"EGAN BM is a researcher primarily focused on cardiovascular health, with a particular emphasis on hypertension and prehypertension treatment. Their work includes studies on the efficacy of single-pill combinations in improving hypertension control. This dual focus highlights their expertise in both early-stage blood pressure management (prehypertension) and advanced therapeutic strategies (single-pill combinations) for hypertension.  \n\nBy integrating these descriptions, it is clear that EGAN BM contributes to research aimed at optimizing blood pressure management across different stages of the condition.\",3\n2694,KJELDSEN SE,\"Kjeldsen SE is a researcher involved in studies on single-pill combinations and hypertension control.\"\"\",2\n2704,LAU T,\"Lau T is a researcher involved in studies on hypertension management in Eastern Asians.\"\"\",2\n3118,FACCHETTI R,\"A researcher involved in multiple hypertension-related studies, including white-coat hypertension>\",2\n3131,CUSPIDI C,\"**CUSPIDI C** is a researcher primarily focused on studies related to nocturnal blood pressure, white-coat hypertension, and their clinical implications. Their work includes conducting meta-analyses to investigate the relationship between nocturnal hypertension and organ damage, contributing to a deeper understanding of cardiovascular health. By examining these specific aspects of hypertension, CUSPIDI C aims to advance knowledge in the field and inform better diagnostic or therapeutic approaches.\",4\n3132,PAOLETTI F,A researcher involved in studies on nocturnal blood pressure and white-coat hypertension>,1\n3165,EURECA-M,\"European Renal and Cardiovascular Medicine working group of the ERA-EDTA and ESH\"\"\",4\n3166,ERA-EDTA,\"European Renal Association-European Dialysis and Transplant Association\"\"\",1\n3174,SARAFIDIS PA,\"Researcher involved in EURECA-m consensus on hypertension in dialysis patients\"\"\",1\n4572,CATAPANO AL,\"Co-author of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias\"\"\",1\n4690,DITMARSCH M,\"Researcher involved in the phase 2 trial of CETP inhibitor obicetrapib\"\"\",1\n4692,NAT MED,\"Journal where the phase 2 trial of CETP inhibitor obicetrapib was published\"\"\",4\n4691,KASTELEIN JJ,\"Researcher involved in the phase 2 trial of CETP inhibitor obicetrapib\"\"\",1\n4714,CETP INHIBITOR OBICETRAPIB,\"Drug studied in combination with statins for lipid lowering effects\"\"\",1\n2321,SAITO I,\"A researcher involved in a large-scale observational study on home blood pressure and cardiovascular outcomes\"\"\",1\n2343,KUSHIRI T,,1\n2437,WORLD HEALTH ORGANIZATION-INTERNATIONAL SOCIETY OF HYPERTENSION (WHO-ISH),\"Collaborative body setting global hypertension management guidelines\"\"\",1\n2725,ASIAN PACIFIC HEART ASSOCIATION,,1\n3014,MAHMOUD AN,A researcher involved in meta-analysis of aspirin for primary prevention of cardiovascular events,3\n3032,GAD MM,Researcher involved in meta-analysis of aspirin for primary prevention,1\n3033,ELGENDY AY,Researcher involved in meta-analysis of aspirin for primary prevention,1\n3143,BULPITT CJ,Bulpitt CJ is a researcher who studied white-coat hypertension in the very elderly trial>,1\n3172,ISHIKAWA J,\"Researcher involved in J-MORE study on morning hypertension\"\"\",1\n3331,NEUROLOGY,\"**NEUROLOGY** is a journal dedicated to publishing research on neurological conditions, including dementia. For instance, it has featured studies examining the relationship between blood pressure from mid-to late life and the risk of incident dementia. The journal serves as a key resource for advancing understanding in the field of neurology through peer-reviewed research and findings.\",3\n3345,SPRINT-MIND TRIAL,\"A clinical trial investigating the effects of blood pressure lowering on cognitive decline\"\"\",1\n4677,NICHOLLS SJ,\"NICHOLLS SJ is a researcher who has been involved in multiple clinical trials, including the STRENGTH Randomized Clinical Trial, which investigated the effects of omega-3 fatty acids. Additionally, he has participated in a phase 2 trial focusing on the CETP inhibitor obicetrapib, demonstrating his involvement in cardiovascular and metabolic research. His work spans different therapeutic areas, contributing to advancements in lipid-modifying therapies.\",2\n2679,FLETCHER AE,A researcher involved in hypertension treatment for elderly patients,1\n3146,JULIUS S,Julius S is a researcher who studied the feasibility of treating prehypertension with an angiotensin-receptor blocker>,2\n3155,NESBITT SD,Nesbitt SD is a researcher who studied the feasibility of treating prehypertension with an angiotensin-receptor blocker>,1\n3221,WARWICK J,\"Warwick J is a researcher whose work focuses on the intersection of aging, cardiovascular health, and cognitive decline. He has studied the relationship between blood pressure and dementia, as well as the effects of frailty on antihypertensive treatment in very elderly populations. His research contributes to understanding how aging-related conditions, such as frailty, influence the management of hypertension and its potential implications for cognitive health.\",2\n3224,HYVET STUDY,\"The Hypertension in the Very Elderly Trial (HYVET) is a clinical study investigating the effects of antihypertensive treatment in people aged 80 and over.\"\"\",1\n4671,GORDON SM,\"A researcher involved in a study on niacin monotherapy for HDL composition and function\"\"\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3444,JAMA NEUROL,EUR HEART J,Both journals published studies on blood pressure and cognitive outcomes,17\n3824,EUR HEART J,HERB-DH1 PIVOTAL TRIAL,The trial results were published in Eur Heart J,14\n2437,EUR HEART J,O'DONNELLM,O'DonnellM's research on salt and cardiovascular disease was published in Eur Heart J,13\n2438,EUR HEART J,MENTEA,MenteA's research on salt and cardiovascular disease was published in Eur Heart J,13\n2439,EUR HEART J,ALDERMAN MH,Alderman MH's research on salt and cardiovascular disease was published in Eur Heart J,13\n2440,EUR HEART J,KIM MS,Kim MS's research on adiposity and cardiovascular outcomes was published in Eur Heart J,13\n2441,EUR HEART J,KIM WJ,Kim WJ's research on adiposity and cardiovascular outcomes was published in Eur Heart J,13\n2442,EUR HEART J,KHERAAV,KheraAV's research on adiposity and cardiovascular outcomes was published in Eur Heart J,13\n3452,EUR HEART J,WHITEHALL II,The Whitehall II study was published in the European Heart Journal,13\n2552,KARIO K,HONEST STUDY,Kario K led the HONEST study on home blood pressure,12\n2845,WANG JIANGUANG,KARIO K,Both researchers collaborated on studies on hypertension management in Eastern Asians.,12\n2601,KARIO K,WANG TD,Co-authors of HOPE Asia Network consensus,11\n2602,KARIO K,TOMITANI N,Co-authors of HOPE Asia Network consensus,10\n2641,MANCIA G,NARKIEWICZ K,Co-authors of ESH/ESC hypertension guidelines,10\n3279,MANCIA G,ELSA STUDY,Mancia G was involved in the ELSA study,10\n3318,HOPE ASIA NETWORK,ESH,Both organizations focus on hypertension research and management,10\n2640,MANCIA G,FAGARD R,Co-authors of ESH/ESC hypertension guidelines,8\n3003,YANO Y,HOSHIDE S,Yano Y and Hoshide S are co-authors of the JET study,8\n3006,HOSHIDE S,TAMAKI N,Hoshide S and Tamaki N are co-authors of the JET study,8\n3278,MANCIA G,BOMBELLI M,Both researchers collaborated on multiple hypertension-related studies,8\n3331,J-MORE,HOSHIDE S,Hoshide S was involved in J-MORE morning hypertension research,8\n2631,EUROPEAN SOCIETY OF HYPERTENSION (ESH),EUROPEAN SOCIETY OF CARDIOLOGY (ESC),Joint task force for arterial hypertension management,7\n3005,YANO Y,JET STUDY,Yano Y is an author of the JET study,6\n3008,TAMAKI N,JET STUDY,Tamaki N is an author of the JET study,6\n3310,HYPERTENSION IN THE VERY ELDERLY TRIAL,PETERS R,Peters R was involved in the Hypertension in the Very Elderly Trial,6\n3319,ARTEMIS STUDY,J-MORE,Both studies investigate morning blood pressure patterns,6\n3446,JAMA NEUROL,KITAGAWA K,Kitagawa K published research in JAMA Neurology,6\n3447,JAMA NEUROL,ARIC,The ARIC study was published in JAMA Neurology,6\n4444,MACH F,EUROPEAN SOCIETY OF CARDIOLOGY (ESC),Mach F co-authored guidelines published by the ESC,6\n4510,NIACIN,OMEGA-3 FATTY ACIDS,Both are studied for their effects on lipid metabolism,6\n4511,TADIC M,OMEGA-3 FATTY ACIDS,Tadic M researched the effects of omega-3 fatty acids on coronary artery disease,6\n4512,OMEGA-3 FATTY ACIDS,STRENGTH RANDOMIZED CLINICAL TRIAL,The trial studied the effects of omega-3 fatty acids on cardiovascular events,6\n2818,BECKETT NS,PETERS R,Collaborated on hypertension treatment for elderly patients,5\n2832,EGAN BM,KJELDSEN SE,Both researchers collaborated on studies on single-pill combinations and hypertension control.,5\n2834,KJELDSEN SE,NARKIEWICZ K,Both researchers collaborated on studies on single-pill combinations and hypertension control.,5\n2846,WANG JIANGUANG,LAU T,Both researchers collaborated on studies on hypertension management in Eastern Asians.,5\n3280,FACCHETTI R,ELSA STUDY,Facchetti R was involved in the ELSA study,5\n3287,CUSPIDI C,PAOLETTI F,Both researchers collaborated on studies about nocturnal blood pressure,5\n3322,EURECA-M,ERA-EDTA,EURECA-m is a working group under ERA-EDTA,5\n3324,EURECA-M,SARAFIDIS PA,Sarafidis PA contributed to EURECA-m consensus document,5\n4447,CATAPANO AL,EUROPEAN SOCIETY OF CARDIOLOGY (ESC),Catapano AL co-authored guidelines published by the ESC,5\n4525,DITMARSCH M,NAT MED,Ditmarsch M was a researcher in a study published in Nat Med,5\n4526,KASTELEIN JJ,NAT MED,Kastelein JJ was a researcher in a study published in Nat Med,5\n4527,NAT MED,CETP INHIBITOR OBICETRAPIB,Study of CETP inhibitor obicetrapib was published in Nature Medicine,5\n2577,SAITO I,HONEST STUDY,Saito I co-authored the HONEST study,4\n2578,HONEST STUDY,KUSHIRI T,Kushiro T co-authored the HONEST study,4\n2630,WORLD HEALTH ORGANIZATION-INTERNATIONAL SOCIETY OF HYPERTENSION (WHO-ISH),EUROPEAN SOCIETY OF HYPERTENSION (ESH),Both organizations develop hypertension management guidelines,4\n2847,WANG JIANGUANG,ASIAN PACIFIC HEART ASSOCIATION,Wang Jianguang contributed to a scientific statement issued by the Asian Pacific Heart Association.,4\n3170,MAHMOUD AN,GAD MM,Co-authors on meta-analysis of aspirin for primary prevention,4\n3171,MAHMOUD AN,ELGENDY AY,Co-authors on meta-analysis of aspirin for primary prevention,4\n3298,BULPITT CJ,HYPERTENSION IN THE VERY ELDERLY TRIAL,Bulpitt CJ was involved in the Hypertension in the Very Elderly Trial,4\n3332,J-MORE,ISHIKAWA J,Ishikawa J was a lead researcher in the J-MORE study,4\n3467,NEUROLOGY,SPRINT-MIND TRIAL,The trial's findings were discussed in the journal Neurology,4\n4515,NICHOLLS SJ,STRENGTH RANDOMIZED CLINICAL TRIAL,Nicholls SJ was involved in the STRENGTH trial,4\n2819,BECKETT NS,FLETCHER AE,Collaborated on hypertension treatment for elderly patients,3\n3302,JULIUS S,NESBITT SD,Nesbitt SD and Julius S studied prehypertension treatment together,3\n3376,WARWICK J,HYVET STUDY,Warwick J was involved in the HYVET study on antihypertensive treatment in very elderly people.,3\n4509,GORDON SM,NIACIN,Gordon SM studied the effects of niacin on HDL composition,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_0b261877134f7f76b36835da912492233a33ceebcc20517733a04a2b12a2c3e7_v2"}